Advertisement
Australia markets closed

  • ALL ORDS

    7,970.80
    +74.90 (+0.95%)
     

  • ASX 200

    7,701.70
    +73.50 (+0.96%)
     

  • AUD/USD

    0.6655
    +0.0021 (+0.31%)
     

  • OIL

    77.18
    -0.73 (-0.94%)
     

  • GOLD

    2,347.70
    -18.80 (-0.79%)
     

  • Bitcoin AUD

    101,571.61
    -633.80 (-0.62%)
     

  • CMC Crypto 200

    1,422.58
    -5.98 (-0.42%)
     

  • AUD/EUR

    0.6132
    +0.0014 (+0.23%)
     

  • AUD/NZD

    1.0824
    -0.0020 (-0.19%)
     

  • NZX 50

    11,867.29
    +310.08 (+2.68%)
     

  • NASDAQ

    18,536.65
    -2.01 (-0.01%)
     

  • FTSE

    8,275.38
    +44.33 (+0.54%)
     

  • Dow Jones

    38,686.32
    +574.84 (+1.51%)
     

  • DAX

    18,497.94
    +1.15 (+0.01%)
     

  • Hang Seng

    18,079.61
    -150.58 (-0.83%)
     

  • NIKKEI 225

    38,487.90
    +433.77 (+1.14%)
     

InMode to Present at Jefferies Healthcare Conference

PR Newswire
·1-min read

YOKNEAM, Israel, May 16, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present in-person at the Jefferies Healthcare Conference in New York on June 5, 2024.

InMode Logo
InMode Logo

The fireside chat, moderated by Matt Taylor, Managing Director, Senior Healthcare Analyst, is scheduled for 7:30 am Eastern Time on Wednesday, June 5 and a live webcast of the presentation can be accessed here. InMode will also hold one-on-one investor meetings in person that same day. To schedule a meeting, please contact your Jefferies representative.

For more information about the event, visit InMode's investor relations site here.

ADVERTISEMENT

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-jefferies-healthcare-conference-302146710.html

SOURCE InMode LTD